Posttranscriptional controls in higher eukaryotes are central to cell differentiation and developmental programs. These controls reflect sequence-specific interactions of mRNAs with one or more RNA binding proteins. The ␣-globin poly(C) binding proteins (␣CPs) comprise a highly abundant subset of K homology (KH) domain RNA binding proteins and have a characteristic preference for binding single-stranded C-rich motifs. ␣CPs have been implicated in translation control and stabilization of multiple cellular and viral mRNAs. To explore the full contribution of ␣CPs to cell function, we have identified a set of mRNAs that associate in vivo with the major ␣CP2 isoforms. One hundred sixty mRNA species were consistently identified in three independent analyses of ␣CP2-RNP complexes immunopurified from a human hematopoietic cell line (K562). These mRNAs could be grouped into subsets encoding cytoskeletal components, transcription factors, proto-oncogenes, and cell signaling factors. Two mRNAs were linked to ceroid lipofuscinosis, indicating a potential role for ␣CP2 in this infantile neurodegenerative disease. Surprisingly, ␣CP2 mRNA itself was represented in ␣CP2-RNP complexes, suggesting autoregulatory control of ␣CP2 expression. In vitro analyses of representative target mRNAs confirmed direct binding of ␣CP2 within their 3 untranslated regions. These data expand the list of mRNAs that associate with ␣CP2 in vivo and establish a foundation for modeling its role in coordinating pathways of posttranscriptional gene regulation.
Programs of gene expression in eukaryotic cells are coordinated at multiple levels. A significant component of these controls is mediated by posttranscriptional mechanisms. Processing, transport, localization, stability, and translation of an mRNA are often controlled via sequence-specific interactions with RNA binding proteins. Most of these interactions are discovered in the course of exploring specific pathways of gene regulation. Such gene-specific discovery approaches, while highly informative, are not able to focus on the wider impact of particular RNA binding proteins on cell function. A complementary approach that can more effectively address this question would involve the identification of the full spectrum of mRNA targets for a particular RNA binding protein (46) . Such an approach would set the stage for constructing an integrated view of how particular RNA binding proteins contribute to coordination of gene expression profiles (21) .
Limited examples of coordinate control by RNA binding proteins can be cited from the literature. An initial example is represented by the iron response element binding protein (8) . This iron-binding protein can reversibly block translation of ferritin mRNA via 5Ј untranslated region (UTR) binding and reversibly stabilize transferrin receptor mRNA via 3Ј UTR binding. These distinct actions of the iron response element binding protein coordinate an integrated cellular response to intracellular iron levels. By defining the full-spectrum target mRNAs for specific RNA binding proteins, it may be possible to define even more complex posttranscriptional control networks. Recent examples are the identification of subsets of mRNAs bound by the K homology (KH)-domain fragile X mental retardation protein (5) and segregation of nuclear mRNAs into distinct sets of RNPs during nuclear-cytoplasmic export (17) . The concept of coordinate control of multiple genes by RNA-binding proteins has been recently proposed in terms of posttranscriptional operons (21) .
The ␣-globin poly(C) binding proteins (␣CPs), also known as hnRNP E (34) or poly(C) binding proteins (PCBP) (1, 23, 24) , comprise a family of highly abundant and widely expressed RNA binding proteins. Multiple ␣CP isoforms are encoded by four dispersed paralogous loci (29, 31, 32, 48) . The two most abundant and widely expressed of these proteins, ␣CP2 and ␣CP2-KL, are encoded by alternative splicing of the ␣CP2 transcript (10) . ␣CPs are conserved across several genera: orthologues of ␣CPs are found in Xenopus laevis, Drosophila melanogaster, Caenorhabditis elegans, and Saccharomyces cerevisiae (32) . The abundant expression, widespread tissue distribution (24, 29, 31) , and evolutionary conservation of ␣CPs suggest that they serve fundamental functions.
Each ␣CP isoform contains a characteristic triple repeat of the 70-amino-acid heteronuclear ribonucleoprotein (hnRNP) KH domain. The KH domain is common to a wide spectrum of RNA binding proteins (13) and can interact via a molecular vise with four to five contiguous bases in a target RNA (25, 26) . Since KH domains can interact independently with RNA sequences, arrays of such motifs in a protein can generate substantial complexity and specificity of RNA interactions.
␣CPs have a characteristic preference for binding to singlestranded C-rich motifs, and binding to these elements has been linked to a number of posttranscriptional controls (2, 12, 35, 36, 38, 45, 52, 53) . The initial function defined for ␣CPs was stabilization of human ␣2-globin (␣-globin) mRNA (6, 23, 52, 53) via binding to a 3Ј UTR C-rich motif (52) . ␣CP1 and ␣CP2 have also been linked to stabilization of ␣1(I) collagen and tyrosine hydroxylase mRNAs via interacting with respective C-rich 3Ј UTR motifs (38, 45) . Based on these and other studies (9, 55) , it has been proposed that the complex between ␣CP and the cis-acting stability elements, referred to as the ␣-complex (52), constitutes a general determinant of high-level mRNA stability (18) .
In addition to its role in mRNA stabilization, ␣CP also functions in a range of translation controls. Binding of ␣CP1 and hnRNP K to the 3Ј UTR of 15-lipoxygenase mRNA maintains the mRNA in a translationally silent state until the final stages of erythroid differentiation (35) . ␣CP2-mediated translational control also appears to be involved in the pathological block in CCAAT/enhancer binding protein ␣ (c/EBP␣) expression in myelogenous leukemia via binding to a C-rich intercistronic motif (39) . ␣CPs can also facilitate translation of cellular mRNAs. For example, translational activation is mediated by binding of ␣CP to the 5Ј UTR of the folate receptor ␣ mRNA (54) and binding to a 3Ј UTR C-rich motif in the phosphatase 2A mRNA (36) . ␣CPs bind to several viral mRNAs, and the corresponding RNP complexes are involved in many aspects of the viral life cycle (3, 4, 7, 11, 12, 14, 16, 33, 37, 44, 51) . Several of these studies indicate that functional interactions may be specific for particular ␣CP isoforms, may work in conjunction with additional RNA binding proteins, and may be impacted by cellular differentiation (7, 35) .
Five mRNAs have been identified in a screen for ␣CP1 binding targets: mitochondrial NADH dehydrogenase subunit 3, mitochondrial cytochrome c oxidase subunit II (coxII), ribosomal protein of the large subunit (L27a), palmitoylated erythrocyte membrane protein p55, manganese superoxide dismutase, and the CD81 receptor (TAPA-1) (49) . The mRNAs encoding TAPA-1 and coxII were further shown to contain ␣CP1 binding sites in the 3Ј UTRs by in vitro binding assays. It is unknown whether these mRNAs constitute ␣CP1 binding targets in vivo, and the function of these ␣CP1-RNP complexes remains undefined.
The variety of ␣CP targets and control mechanisms suggests that the ␣CP-RNP complexes play significant and multifaceted roles in gene expression. Identification of additional mRNA targets would facilitate further exploration of this potential. In this study, we have attempted to identify a spectrum of in vivo binding targets of the major ␣CP2 isoforms by microarray analysis of immunopurified cytoplasmic ␣CP2-RNPs. Three independent studies revealed that 160 mRNAs were specifically and reproducibly present in the ␣CP2-RNP complexes. These data expand the list of ␣CP2 binding mRNAs and suggest targets for subsequent studies of potential coordinated cell functions.
MATERIALS AND METHODS
Preparation of cytoplasmic extracts. Extracts were prepared (20) from logarithmically growing (0.5 ϫ 10 6 to 1.0 ϫ 10 6 cells/ml) K562 cells (ATCC no. CCL-243) grown under standard conditions. Cells were harvested by centrifugation at 258 ϫ g for 5 min at 4°C, washed with 150 packed cell volumes (pcv) of phosphate-buffered saline (PBS) (Invitrogen) and washed again in 2 pcv of PBS. After sedimentation at 157 ϫ g for 5 min at 4°C, the pellets were resuspended in 3.1 pcv of extraction buffer (15 mM Tris HCl [pH 7.4], 15 mM MgCl 2 , 150 mM NaCl, and 0.65% Igepal). The lysate was incubated on ice for 10 min with shaking and centrifuged at 11,750 ϫ g for 10 min at 4°C. The cytoplasmic lysate was supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF) (Sigma), 3 g of leupeptin/ml (Roche), 1 g of aprotinin/ml (Sigma), and 13% glycerol and was stored at Ϫ80°C. RNP IP. Protein A-Sepharose (PAS) (Amersham) was washed three times in PBS (Invitrogen) at room temperature. Two hundred microliters of a 50% slurry of PAS and PBS was incubated with 5 l of FF3 (anti-␣CP2 and ␣CP2-KL) or anti-c-myc (Santa Cruz) antibodies in the presence of 0.35 U of anti-RNase/l (Ambion) in PBS in a volume of 1.0 ml. The FF3 immunoprecipitates (IPs) are referred to as anti-␣CP2, and the c-myc IPs are referred to as control. The mixtures were incubated for 1 h at 4°C, and the PAS was washed once with PBS. The K562 cytoplasmic extract (2.1 mg/IP) was centrifuged at 11,750 ϫ g for 10 min at 4°C. The supernatant was diluted fourfold in binding buffer (BB) (20 mM HEPES [pH 7.9] and 150 mM NaCl) containing 0.05% Triton X-100. AntiRNase (Ambion) was added to 0.15 U/l. This extract was added to the PAS, incubated for 1 h at 4°C, and washed twice in BB containing 0.05% Triton X-100, followed by two washes in BB containing 1% Triton X-100. The PAS was resuspended in BB containing 0.05% Triton X-100, and the suspension was transferred to a fresh tube. The PAS was pelleted and resuspended in elution buffer (100 mM Tris-HCl [pH 7.4], 12.5 mM EDTA, 150 mM NaCl, and 1% sodium dodecyl sulfate [SDS] ). The mixture was incubated for 3 min at 100°C, phenol extracted, ethanol precipitated with glycogen (20 g; Boehringer), and resuspended in 20 l of H 2 O.
Reverse transcription-PCR. Copurified RNA (1.5 l) was incubated with 1 pmol of reverse primer (listed in Table 1 ), 1 mM each dNTPs, 2.5 U of antiRNase (Ambion), 50 U of Moloney murine leukemia virus reverse transcriptase (Promega), and 1ϫ Moloney murine leukemia virus reverse transcription (RT) buffer (Promega) in a volume of 12.5 l. After incubation at 37°C for 1 h, the samples were used as a template for PCR. The PCR primers are listed in Table   TABLE 1. RT-PCR primers   mRNA DNA length (bp) Primer set (forward, reverse) a 315  5Ј-GTGGACGACATGCCCAACGC-3Ј, 5Ј-CCCACTCAGACTTTATTCAA-3Ј  ␥-Globin  279  5Ј-AAGGTGCTGACTTCCTTGGG-3Ј, 5Ј-ATCCTTGAAAGCTCTGCATC-3Ј (49)  GAPDH  180  5Ј-CAACTACATGGTTTACATGTTC-3Ј, 5Ј-GCCAGTGGACTCCACGAC-3Ј  SAP49  270  5Ј-AACCGCTGCTGTGGGAACTGTTTC-3Ј, 5Ј-GCAACTTCTCATCAATCTCAGGGTC-3Ј  SAP62  361  5Ј-CACTTCACAACAATGAGGGGAGC-3Ј, 5Ј-AAGGCAATGGTCTCGTAGGGTTCG-3Ј  Trx2  239  5Ј-TTGGCTGACAAGCAGGGATGAG-3Ј, 5Ј-AAAGGCGTATGGGAGGGAAGAC-3Ј  ␣CP2,  b ␣CP2-KL  360, 330, 237  5Ј-GGGGTACCTGTTCTAGCTGCWCCCCAT-3Ј (RT), 5Ј-CGTGACCATYCCGTACC-3Ј,  5Ј-TTTGGAATGGTGAGTTCATG-3Ј (29)  C-Src  328  5Ј-GGAACAAAGTCGCCGTCAAGTG-3Ј, 5Ј-TCCTCAGACACCAGCACATTGC-3Ј  JunD  230 5Ј-GAGAAGAACAGAGTGTTCGAT-3Ј, 5Ј-ACAGGAATGTGGACTCGTAGC-3Ј A-Raf-1 113 5Ј-AAAGTATACCTGCCCAACAA-3Ј, 5Ј-CAGCAGTCCTGATTTAGACC-3Ј Cln2 267 5Ј-TCCCCACTGCTACTACCTTA-3Ј, 5Ј-CAAGAGTGAGAGTTCCTTGG-3Ј PPT2 215 5Ј-CCTCTCCACAGATGGGACAGTATG-3Ј, 5Ј-GGCATTGGGATGGTCTCTTTCC-3Ј coxll 106 5Ј-GCAAACCACAGTTTCATGCC-3Ј, 5Ј-GGCTCTAGAGGGGGTAGAGG-3Ј (49) 1. The forward primer (8 pmol) was end labeled by incubation with 5 l of [␥-32 P]rATP (6,000 Ci/mmol), 1ϫ forward reaction buffer (Gibco), and 10 U of T4 polynucleotide kinase (Gibco) for 30 min at 37°C and at 65°C for 10 min. The PCRs included 5 l of the RT product, 0.2 mM dNTPs, 1.5 mM MgCl 2 , 2.5 l of the labeled primer, 2.5 g of each primer, 0.25 U of AmpliTaq (Perkin Elmer), and 1ϫ PCR buffer II (Perkin Elmer). Thermocycler conditions were 95°C for 3 min followed by 30 cycles of 95°C for 1 min, 52°C for 1 min, and 72°C for 1 min followed by a final cycle of 72°C for 10 min. Samples were visualized by 5% polyacrylamide gel electrophoresis (PAGE) and quantified by the PhosphorImager (ImageQuant; Molecular Dynamics).
␣-Globin
Amplification of antisense mRNA probes. The copurified RNA was amplified as described previously (40) with modifications. One hundred picomoles of T7-oligo(dT) 24 primer (Affymetrix sequence; GenSet Oligos) was added to the RNA. After heating at 70°C for 10 min and 42°C for 5 min, first-strand cDNA was synthesized using the SuperScript Choice kit (InVitrogen). Conditions consisted of 0.01 M dithiothreitol (DTT), 0.5 mM dNTPs, 10 U of Superscript II reverse transcriptase/l and 1ϫ first-strand buffer in a volume of 20 l. After incubation at 42°C for 1 h, second-strand cDNA was synthesized with 0.2 mM dNTPs, 0.26 U of DNA polymerase I/l, 0.013 U of RNaseH/l, 0.07 U of DNA ligase/l, and 1ϫ second-strand buffer. The samples were incubated at 16°C for 2 h. T4 DNA polymerase was added (0.07 U/l) and incubated for 10 min at 16°C. The product was phenol extracted followed by purification using a YM-50 filter (Millipore). Antisense mRNA was synthesized using the T7 MEGAscript kit (Ambion) and was extracted and purified on a YM-50 filter (Millipore). Random hexamers (2 g; Amersham) were added, and the volume was adjusted to 20 l. After incubation at 70°C for 10 min, on ice for 2 min, and at room temperature for 10 min, first-strand cDNA was synthesized using the SuperScript Choice kit (InVitrogen) in a volume of 40 l. The samples were treated with 0.1 U of RNase H/l, incubated at 37°C for 20 min and 94°C for 2 min, and placed on ice. T7-oligo(dT) 24 primer was added (final concentration, 200 pmol) and incubated at 70°C for 5 min and then at 42°C for 10 min. Second-strand synthesis was performed as described above except that the volume was 300 l and the DNA ligase was omitted. After incubation at 16°C for 2 h, the product was extracted and purified using a YM-50 filter (Millipore). This double-stranded (ds) cDNA was used in another RNA amplification by repeating the antisense mRNA and ds cDNA synthesis [i.e., with the first strand being primed by using random hexamers and second strand being primed by using the T7-oligo(dT) 24 ]. The ds cDNA contained a T7 promoter followed by cDNA encoding the antisense mRNA of the copurified mRNA. This cDNA was then used as template to generate radiolabeled antisense mRNA to probe the slot blot or to generate biotinylated antisense mRNA to probe the microarray (see below).
In vitro RNA synthesis. 32 P-labeled RNA for the slot blot hybridization was synthesized using the T7 MEGAshortscript kit (Ambion). The ds cDNA from the antisense mRNA amplification (see above) was used as a template. The final concentration of rATP, rGTP, and rUTP was 5.6 mM, and the final concentration of unlabeled rCTP was 0.08 mM. Three microliters of [␣-32 P]rCTP (400 Ci/mmol) was used per reaction. The RNA was purified using an RNAeasy column (Qiagen), and 3.3 ϫ 10 6 cpm of probe was used per slot blot. Biotinylated RNA probe for the microarray hybridization was synthesized using a BioArray high-yield RNA transcript labeling kit (Enzo). The ds cDNA from the antisense mRNA amplification (see above) was used as a template. The RNA was purified, quantified, and fragmented according to Affymetrix protocols. Equal masses of probe (7 to 12 g/microarray for three studies) were used for each set of microarrays.
4-thio-rUTP RNA probes for the cross-linking studies were synthesized as described previously (50) . Two micrograms of EcoRI-linearized pSP6-(Trx2 or SAP49 or ␣-Globin)3ЈUTRpolyA (see below) and 1 g of pTRI-␤-actin-mouse (which generates ␤-actin antisense RNA) (Ambion) were used as template. The Maxiscript SP6 kit (Ambion) was utilized with final concentrations of rUTP (0.5 mM), rCTP (12 M), and 4-thio-rUTP (0.25 mM) and 2.6 l of [␣-
32 P]rCTP (3,000 Ci/mmol). The RNA was purified using an RNAeasy column (Qiagen), and 1.5 ϫ 10 6 cpm of RNA was used per reaction. RNA probes for the electrophoretic mobility shift assay (EMSA) studies were generated using the Maxiscript SP6 kit (Ambion) with 1 g of EcoRI-linearized pSP6-(Trx2 or SAP49 or ␣-Globin)3ЈUTRpolyA, 0.5 g of pTRI-␤-actin-mouse (Ambion), with a rCTP (12 M) and 5 l of [␣-
32 P]rCTP (400 Ci/mmol). RNA was purified (RNAeasy; Qiagen), and 7 ϫ 10 5 to 9 ϫ 10 5 cpm of RNA was used in each EMSA.
Slot blot hybridization. Tenfold dilutions of plasmids (8 to 800 ng) containing the cDNAs encoding h␣2-globin and ␤-actin cDNA or PUC19 vector were diluted 100-fold in 0.4 M NaOH, transferred via slot blot vacuum manifold to Zetabind nylon (Cuno), and incubated in 0.4 M NaOH at room temperature for 5 min. The membrane was neutralized in 0.2ϫ SSC (1ϫ SSC is 150 mM NaCl and 15 mM sodium citrate)-0.2 M Tris (pH 7.5) at room temperature for 2 min and cross-linked in the UV Stratalinker 2400 (autocross-link) (Stratagene). The membrane was washed in 0.1ϫ SSC-0.1% SDS at 65°C for 30 min and prehybridized in 0.5 M NaPO 4 (pH 7.2), 7% SDS, 1% bovine serum albumin, and 0.1 mM EDTA at 65°C for 4 h. Then, 3.3 ϫ 10 6 cpm was incubated with the membrane at 42°C overnight in a buffer of 5ϫ SSC, 5ϫ Denhardt's, 50% formamide and 1% SDS. After washing two times with 1ϫ SSC-0.1% SDS at 42°C for 15 min and at 42°C for 30 min, the membranes were rinsed in 2ϫ SSC and exposed to the PhosphorImager, and signals were quantified (ImageQuant; Molecular Dynamics).
Microarray hybridization and data analysis. The biotinylated cRNAs were hybridized to the Affymetrix human genome U95A microarrays at the MIT biopolymers lab. For each set of microarray experiments, an equal mass of antisense RNA was used as the probe. The image ("dat") files were analyzed using Microarray Suite (MAS) version 5.0 (Affymetrix). A comparison analysis was performed between the experimental ␣CP2 microarray and the baseline control microarray for each experiment. The comparison files for each of three independent experiments were compiled into a single Excel file. This file was sorted to include those mRNAs that were designated "present" (i.e., detected) by MAS and those which showed an enrichment in the ␣CP2 microarray relative to the control microarray. The cutoff value for enrichment was twofold. The signal log ratio value, which reflects the abundance of an mRNA, was averaged among the three independent microarray experiments for each mRNA. This average signal log ratio was used to calculate the fold enrichment according to equations from Affymetrix. These fold enrichment values were normalized to the fold enrichment value calculated for the ␥-globin mRNA negative control. The individual normalized fold change (INFC) for each independent microarray experiment and the averaged normalized fold change (Avg NFC) for all three studies are represented in Table 2 . The ranking of the mRNAs is based on the Avg NFC value.
Cloning of the Trx2 and SAP49 3 UTRs. The 3Ј UTRs of Trx2 and SAP49 were amplified using primers that contained HindIII or SacI sites (underlined), namely, 5ЈAAGCTTGCTGATTGGCTGACAAGCAGGG3Ј and 5ЈGAGCTC GACATTGCAGATGGTGCAGACCC3Ј (for Trx2) and 5ЈAAGCTTCAGTAA ATTCACATTTTCCTTCC3Ј and 5ЈGAGCTCAAACAAGGAGTTTAGTTTT ATTTTC3Ј (for SAP49). The templates for PCR were human I.M.A.G.E. clones 2446364 (Trx2) and 38675 (SAP49) from Research Genetics. The PCRs consisted of the following: 0.2 mM dNTPs, 1.5 mM MgCl 2 , 0.05 g of each primer, 1ϫ PCR Buffer II (Roche), 0.04 g of template, and 1.25 U of AmpliTaq (Roche). The conditions were 95°C for 3 min; 20 cycles of 94°C for 1 min, 56°C (SAP 49) or 64°C (Trx2) for 1 min, and 72°C for 1 min; and 72°C for 10 min. Fragments were gel isolated using Qiaex II (Qiagen) and ligated into pGemT (Promega), and clones were verified by sequencing. Plasmids were digested with HindIII and SacI, and the fragments were purified and ligated into the same sites in pSP64polyA (Promega). The constructs contained an SP6 promoter linked to the cDNAs encoding Trx2 or SAP49 3Ј UTRs and a (dT-dA) 30 cassette followed by an EcoRI site. These plasmids are named pSP6-(Trx2 or SAP49)3ЈUTRpolyA. The pSP6-␣-Globin 3ЈUTRpolyA has the same structure described above, except that it contains the 3ЈUTR of ␣2-globin mRNA.
RNA binding studies. RNA EMSAs were carried out as described previously (6) . UV cross-linking reactions were performed as described previously (50) with modifications. Thirty-five micrograms of the K562 extract was incubated in crosslinking buffer (8.5 mM HEPES [pH 7.4], 3.0 mM MgCl 2 , 27.0 mM KCl, and 1.0 mM DTT) with RNA (6 ϫ 10 6 cpm; 90 nM) in the presence or absence of unlabeled competitor RNA. After irradiation and RNase digestion, the samples were immunoprecipitated with FF3 or control antibodies using the conditions described above for the RNP IP. The products were resolved by SDS-10% PAGE. Competition experiments were analyzed by the PhosphorImager and quantitated using ImageQuant (Molecular Dynamics).
RESULTS
Verification of ␣CP-RNP IP: ␣-Globin mRNA interacts with ␣CP in vivo. An ␣CP2-RNP IP strategy was established to isolate and identify a set of mRNAs that interact in vivo with ␣CP2 and its major splice variant form, ␣CP2-KL. The K562 cell line was chosen for this analysis. This human erythroid cell line contains high levels of human ␣-globin and ␥-globin mRNAs which can serve as positive and negative controls, respectively, for the IP reaction; interaction of ␣-globin mRNA VOL. 23, 2003 MICROARRAY IDENTIFICATION OF ␣CP2-ASSOCIATED mRNAS with ␣CP2 has been previously characterized in detail and has a defined biologic function (23), while ␥-globin mRNA lacks ␣CP binding sites (49) . Native ␣CP2-RNP complexes were immunoprecipitated from K562 cytoplasmic extracts using an affinity-purified rabbit antiserum specific to the two predominant human ␣CP isoforms, ␣CP2 and ␣CP2-KL (anti-␣CP2) (6) . As a specificity control, a parallel set of IPs (control IP) was carried out using an unrelated rabbit antiserum. Rabbit anti-human c-myc was used for this purpose. Parameters were established to maximize the yield and the specificity of ␣CP2-RNP complex IP (see Materials and Methods). To assess this approach, the relative contents of ␣-globin or ␥-globin mRNAs were compared in the RNA isolated from the anti-␣CP2 IP and the control IP by targeted RT-PCR (Fig. 1A) . ␣-Globin mRNA was enriched by 100-fold in the ␣CP2-RNP IP (lane 1) compared to the control IP (lane 2). In contrast, the contents of ␥-globin mRNA in the two preparations were within twofold of each other (lane 3 versus lane 4). As ␥-globin mRNA does not interact with ␣CP, this ratio of ␥-globin in the two preparations establishes the background ratio for comparisons of enrichment in each study (see below). These data demonstrate robust enrichment of ␣-globin mRNA in the ␣CP2-RNP com- plexes and establish in vivo association of ␣-globin mRNA with ␣CP2 in K562 cells. ␣-Globin mRNA enrichment in the ␣CP2-RNP preparation is maintained during antisense probe amplification. The optimized IP approach was applied to the identification of mRNAs present in ␣CP2-RNP complexes in K562 cells. To generate sufficient probe for a full set of microarray hybridizations, mRNAs copurified from each RNP preparation were cycled through an amplification protocol (see Materials and Methods). This protocol generates ds cDNAs that carry a T7 promoter. Subsequent in vitro transcription from this T7 promoter generates antisense probes complementary to the initial mRNA pools. To determine whether the representation of mRNAs in the ␣CP2-RNP complexes is maintained during the amplification procedure, radiolabeled antisense mRNA pools (see Materials and Methods) were used to probe a slot blot containing cDNAs encoding a set of control sequences: ␣-globin, ␤-actin, or pUC19. ␤-Actin represents an mRNA unassociated with ␣CP2, and pUC19 serves as a control for nonspecific hybridization. The results are shown in Fig.  1B . There was equivalent low-level hybridization to pUC19 sequences and to the ␤-actin cDNA using probes derived from the anti-␣CP2 and control IPs. In contrast, ␣-globin mRNA was enriched approximately 200-fold relative to the control IP and 55-fold relative to the unfractionated (total) K562 RNA pool. These data demonstrate that the amplification procedure maintains the enrichment of ␣-globin mRNA and support the validity of carrying out amplification of the RNAs prior to probe generation and microarray hybridization.
Microarray analysis of mRNA content in ␣CP2-RNPs isolated from K562 cells. Amplified ds cDNAs from the IP reactions were used as templates to generate biotinylated antisense probes for interrogation of Affymetrix human genome U95A microarrays (12,600 open reading frames). A comparison analysis using Microarray Suite software, version 5.0, was performed for each experiment; the ␣CP2 IP microarray hybridization was designated the experimental microarray, and the control IP microarray hybridization was designated the baseline microarray (see Materials and Methods). Three independent studies were carried out, beginning each time with fresh extract and IP and proceeding through microarray hybridizations (Fig. 2) . The total number of mRNAs detected on the microarrays varied by 1.6-to 2-fold among the three independent hybridizations, as did the number of mRNAs that were scored as enriched in ␣CP2-RNP complexes. Comparison among the data sets revealed a cohort of 160 mRNAs that copurified (i.e., were twofold or more enriched) with ␣CP2-RNP complexes in all three experiments. These mRNAs were considered a maximally reliable set of in vivo ␣CP2-binding targets.
Identification and classification of the 160 mRNAs enriched in ␣CP2-RNPs. The 160 mRNAs that copurified with ␣CP2 in all three IP studies are displayed in Table 2 . cohort of mRNAs was then organized into a series of subsets according to documented or putative functions. The functional assignments should be considered dynamic because several proteins have multiple functions and could have been assigned to alternative groups. Groups with more than three mRNAs are summarized in Fig. 3 . These grouped mRNAs represent 50% of the full list of 160 mRNAs (see Table 2 ). The listing of 160 mRNAs represents a nonrandom set of mRNAs. This conclusion is based on the observation that there is no significant correlation between this list and the compilation of unfractionated mRNAs in the cell; of the 160 most abundant mRNAs in total unamplified K562 mRNA, only 7 were present in the ␣CP2-RNP enriched mRNA population, and of the 160 most abundant mRNAs observed in amplified total K562 RNA, only 6 were present on the list of ␣CP2-interacting mRNAs. Furthermore, inspection of the sequences of many of the 160 mRNAs revealed several potential ␣CP binding sites, defined as C-or CU-rich sequences (see above). The presence of ␣-globin mRNA in the ␣CP2-RNP mRNA cohort (rank no. 3) supports the validity of the IP-microarray screen. The mRNA with the greatest enrichment (80-fold) in the ␣CP2-RNP complexes encoded spliceosomal-associated protein 62 kDa (SAP62). Interestingly, another mRNA encoding a spliceosome-associated protein, SAP49, also ranked high on the list, at no. 20. Of note, ␣CP2 mRNA was present in this list as well; two distinct probe sets on the microarray represent ␣CP2, and both were enriched in the ␣CP2-RNP complexes, ranking at nos. 69 and 83. The mRNA encoding mitochondrial thioredoxin (Trx2) ranked at no. 60, and along with 5 other mRNAs, formed a group of mitochondrial enzymes. Of note, we specifically screened the list of 160 ␣CP2-RNP-associated mRNAs for mRNAs that have been previously proposed as ␣CP binding targets; only ␣-globin was found to be in common (see Discussion).
Confirmation of in vivo ␣CP2-RNP associations by targeted mRNA analysis. Ten mRNAs identified as enriched in the ␣CP2-RNP complexes by the microarray analysis were chosen for confirmatory studies. Anti-␣CP2 or control IP reactions were carried out using fresh K562 extracts, and the copurified mRNAs were directly assayed without prior amplification (Fig.  4) . The candidate mRNAs included ␣-globin, SAP62, SAP49, Trx2, ␣CP2, c-src, junD, a-raf-1, Cln2, and PPT2. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and ␥-globin mRNAs were assayed in parallel as negative controls. In each assay, the ␣-globin mRNA demonstrated robust enrichment in the ␣CP2-RNP population relative to the control IP (Fig. 4A  to E, lanes 1 and 2, respectively) . Each of the 10 mRNAs identified as enriched in ␣CP2-RNPs when assayed by microarray hybridization was confirmed to be enriched when independently assayed by targeted RT-PCR analysis of ␣CP2-RNP preparations. These 10 mRNAs encode SAP49 and Trx2 (Fig. 4A) ; ␣CP2, ␣CP2-KL, and SAP62 (Fig. 4B) ; the protooncoproteins c-src, junD, and a-raf-1 (Fig. 4C) ; and 2 mRNAs which encode factors linked to infantile neuronal ceroid lipofuscinosis, namely, Cln2 and PPT2 (15, 42) (Fig.  4D ). CoxII was also tested for interaction with ␣CP2 by targeted RT-PCR (Fig. 4E) . Even though it is not present on the microarray used in these studies, we wanted to assess whether this mRNA interacts with ␣CP2 because it has been shown previously to be a binding partner of ␣CP1 (49) . Figure 4E shows that coxII mRNA is robustly associated with ␣CP2-RNPs. eIF3b mRNA was included in one of the studies as an example of an additional sequence on the microarray that was not enriched for in the ␣CP2-RNPs. Consistent with the microarray screen, the targeted analysis failed to demonstrate enrichment of this mRNA (data not shown). Taken together, the studies confirm the accuracy of the microarray screen for ␣CP2-associated mRNAs.
The 3 UTRs of SAP49 and Trx2 mRNAs contain ␣CP2 binding sites. SAP49 and Trx2 mRNAs were chosen as representatives for further analysis of ␣CP2 interactions. The specific question was whether the noted in vivo association of these mRNAs with ␣CP2-RNPs reflected direct binding by ␣CP2. The focus on 3Ј UTR interactions was based on the FIG. 2. Summary of three independent microarray analyses of ␣CP2-associated mRNAs. Three independent studies were carried out to identify mRNAs associated with cytosolic ␣CP2-RNPs isolated from K562 cells. The total number of mRNAs detected in the ␣CP2-RNP IPs and the number of mRNAs enriched in each of the ␣CP2-RNP IPs (relative to the control IP) are shown. The percentages represent the quotient of identified mRNAs to total mRNAs represented on the microarray. The number of mRNAs that were enriched in all three microarray surveys is indicated in the lower box. These consistently detected mRNAs are individually listed in Table 2 .
FIG. 3. Major groupings of mRNAs enriched in the ␣CP2-RNP
complexes. The number in parentheses below each category represents the number of mRNAs identified in the group. Note that ␣CP2 and NFB are both represented twice on the microarray (see Table 2 ) but are counted only once in the grouping shown here.
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precedent of documented functional interactions between ␣CPs and 3Ј UTRs of other cellular mRNAs (see above). In cases where ␣CP binding sites have been defined, they contain short patches of C-or CU-rich sequences (2, 12, 35, 36, 38, 45, 52, 53) that are sometimes repeated multiple times (35) . Examination of the 3Ј UTR of SAP49 reveals 12 potential ␣CP binding sites defined as a stretch of C's or U's of more than five nucleotides. The Trx2 3Ј UTR also contains several CU-rich regions, including four CCCUUCC and three CCUCC repeats that are potential ␣CP binding sites. The ability of the 3Ј UTRs of SAP49 and Trx2 to bind cytoplasmic proteins derived from K562 cells was tested in vitro by EMSA. The 3Ј UTR of ␣-globin mRNA and an actin ␤-antisense transcript were included as positive and negative controls, respectively (Fig. 5A) . The 3Ј UTR of SAP49 formed three complexes (designated A, B, and C) with the K562 extract. The Trx2 and ␣-globin 3Ј . Of note, the migration position of complex A is identical to the previously characterized ␣-complex formed between ␣CP and ␣-globin mRNA (6) . In contrast, the other three homoribopolymers had less pronounced effects (lanes 6 to 14). The selective and marked sensitivity of complex A to poly(C) supports the conclusion that the SAP49 3Ј UTR can directly bind ␣CP (for further evidence, see below). The 3 UTRs of SAP49 and Trx2 are directly bound by ␣CP2. UV cross-linking studies were carried out to substantiate a direct interaction of ␣CP2 with the 3Ј UTRs of ␣CP2-RNP-enriched mRNAs. Radiolabeled and thiolated 3Ј UTRs corresponding to the SAP49 or Trx2 3Ј UTRs were UV crosslinked to K562 extract. The 3Ј UTR of ␣-globin mRNA and a ␤-actin antisense transcript were labeled and analyzed in parallel as positive and negative controls, respectively. When the cross-linked products were analyzed by SDS-PAGE, four prominently labeled bands were generated (data not shown). These products appeared to represent nonspecific interactions based on the uniform patterns with the four transcripts and their sensitivity to competition by 18S rRNA. To visualize less abundant complexes that might represent ␣CP2 binding, the cross-linked products were immunoprecipitated with anti-␣CP2 or control antisera (Fig. 5C ). Two immunoprecipitated cross-linked products were observed with anti-␣CP2 antisera, a 38-kDa band and a less intense 36-kDa band that is seen more clearly on longer exposures (data not shown). These two products (double arrow to the right of the gel) correspond to the sizes of the two major ␣CP2 isoforms, ␣CP2 and ␣CP2-KL. These complexes were detected only when the ␣-globin, SAP49, and Trx2 3Ј UTRs were used as probes in the cross-linking (lanes 4, 6, and 8); no immunoprecipitated cross-linked products were observed using the ␤-actin antisense RNA (lanes 1 and 2). A series of cross-competition experiments using the 3Ј UTRs of Trx2 or SAP49 and human 18S rRNA confirmed that ␣CP2 specifically interacted with the Trx2 and SAP49 3Ј UTRs (data not shown). These studies support the conclusion that ␣CP2 can directly and specifically bind to the 3Ј UTRs of SAP49 and Trx2 mRNAs.
DISCUSSION
We have carried out a microarray analysis of human mRNAs present in a specific subset of cytosolic RNP complexes. These complexes are defined by the presence of ␣CP2 and ␣CP2-KL proteins (referred to collectively as ␣CP2) encoded at the PCBP-2 locus. Three independent analyses of the ␣CP2-RNPs reveal a consistent cohort of 160 mRNAs (Table 2) . With the exception of ␣-globin mRNA, these mRNAs represent novel targets of ␣CP2 interaction. How ␣CP2-containing complexes factor into posttranscriptional controls and to what extent such controls might coordinate the expression of subgroups of these mRNAs are questions now open to study.
Several technical aspects and limitations of this approach need to be emphasized. First, the isolation of the ␣CP2-RNPs depends on IP. It is possible that additional ␣CP2-RNP complexes are present in the cell but are not recognized in this 
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procedure due to constraints on protein accessibility and/or subsequent precipitation. Thus, the set of mRNAs identified in this study, while extensive, may not encompass all ␣CP2-mRNPs. Second, the U95A microarray used in this study contains 12,600 probe sets representing approximately 10,500 unique mRNAs. As current estimates of the number of structural genes in the human genome is in the range of 25,000 or more (28) , it is possible that additional targets might be found on subsequent studies using more extensive arrays. Third, the present analysis was limited to cytosolic complexes. The possibility that ␣CP2 binds to additional transcripts in the nucleus is not presently addressed. Fourth, mRNA sequences from the immunoprecipitated RNPs were amplified in order to generate sufficient probe to interrogate a full microarray. While such a step might alter the representation or abundance of sequences in the population, the validity of utilizing amplified RNA probes is supported by prior reports (40) and was confirmed by a series of control experiments (Fig. 1) . Finally, only mRNAs that were enriched (twofold or more) in all three studies were included in the compilation (Table 2 ). This represents a conservative cutoff. Thus, the 160 mRNAs identified in this report should be considered a reliable but not comprehensive representation of K562 mRNAs present in ␣CP2-RNP complexes. It is recognized that the protein contents of the ␣CP2-RNP complexes are unlikely to be homogeneous in composition. Instead, some of these complexes may contain full-length ␣CP2, while others may contain the alternative-splice isoform, ␣CP2-KL. These differences in ␣CP isoform content may mediate distinct sets of protein-protein interactions, generating diverse macromolecular complexes with distinct functions. ␣CP2 may also be subject to posttranslational modifications that may regulate the function and/or composition of the complexes (24) . Finally, the particular mRNA content of the complexes may dictate the protein composition of the RNP complex via allosteric effects on the binding protein, as has been established for certain protein-DNA interactions (42, 47) .
Individual mRNAs identified in the ␣CP2-RNP complexes may be directly bound by ␣CP2, or alternatively, their association with ␣CP2 may be indirect. In the case of human ␣-globin mRNA, ␣CP is known to bind directly and uniquely to the C-rich motifs within the 3Ј UTR (19) . However, it is possible that mRNAs identified in the present survey may be bound by distinct subsets of proteins that are coprecipitated with ␣CP2 as part of macromolecular ␣CP2-RNP complexes (22) . In the limited sampling of the novel mRNAs associated with the ␣CP2-RNPs, direct interaction of the mRNA with ␣CP2 does, in fact, appear to be occurring (Fig. 5) . Thus, for at least two of the novel ␣CP2 mRNPs identified in this study, the specific mRNA inclusion (Trx2 and SAP49) in the complex appears to reflect direct binding by ␣CP2 as determined for ␣-globin mRNA.
It is significant that ␣-globin mRNA was identified in the present screen of ␣CP2-RNPs and that it constituted the thirdmost enriched mRNA (Table 2 ). In contrast, ␥-globin mRNA, which is as abundant as ␣-globin mRNA in K562 cells, was not present in the enriched pool of mRNAs. This selective detection of ␣-globin mRNA supports the validity of the approach and confirms the association of ␣-globin mRNA with these complexes in the cell.
Prior to this study, 14 cellular mRNAs had been reported as targets for ␣CP interaction (see above). Only two of these mRNAs, ␣-globin and coxII, were identified in the present study. There are multiple reasons for the absence of the remaining mRNAs. mRNAs encoding ␣I(I) collagen, tyrosine hydroxylase, androgen receptor, 15-lipoxygenase mRNA, PP 2A ␣, folate receptor ␣, and erythropoietin are represented on the microarray but were not detected by analysis of total K562 mRNA and thus are probably not present in these cells. Likewise, c/EBP␣ mRNA, which is not represented on the microarray, could not be detected by targeted RT-PCR of total K562 mRNA (data not shown), consistent with a previous study which showed that this mRNA is not present in K562 cells (41) .
In contrast, TAPA-1 mRNA (see above) is detected in microarray analysis of total K562 RNA but is not enriched in the immunopurified ␣CP2-RNPs. This may reflect the fact that TAPA-1 was identified as a target of ␣CP1 by prior studies and may be specific to this isoform (49) . Coordination of posttranscriptional controls by particular RNA-binding proteins may occur at a number of steps. We have previously suggested that the ␣-complex may constitute a common determinant of high-level stability (18) . The identification in the present survey of 160 mRNA targets of ␣CP2 can now be used to further test this premise. Fourteen of these mRNAs encode structural cytoskeletal components or proteins involved with cell motility. It is likely that these are long-lived mRNAs based on the premise that proteins that do not need to be acutely controlled are usually encoded by highly stable mRNAs (45) . A second well-defined function of ␣CP is in translation control. Identifying whether any of the 160 cellular mRNAs are subject to this level of control would establish another provisional basis for potential coordination of gene expression by ␣CP2-RNP complexes.
mRNAs encoding 11 enzymes were present in the ␣CP2-RNP population. Two of these enzymes are linked to the pathogenesis of the neurodegenerative disorder infantile neuronal ceroid lipofuscinosis (15, 43) . The identification of these two enzymes, lysosomal pepstatin-insensitive protease (Cln2) (rank no. 54) and palmitoyl-protein thioesterase 2 (PPT2) (rank no. 103), suggests that ␣CP2 might act as a modifier of phenotype in this disease by regulating the available levels of these two enzymes in a coordinate manner. It is also of note that 6 of the 20 total enzyme-encoding mRNAs in the ␣CP2-RNP population direct the synthesis of enzymes specific to the mitochondria. Two of the six mRNAs identified in an independent screen for ␣CP1-associated mRNAs also encoded mitochondrial localized proteins (49) . These data suggest that ␣CPs may coordinate aspects of mitochondrial function or mRNA localization via posttranscriptional mechanisms.
Thirteen ␣CP2-associated mRNAs encode transcription factors. The potential involvement of ␣CP2 in transcription factor expression is consistent with a report showing that ␣CP2 regulates translation of the mRNA encoding the transcription factor, c/EBP␣ (39) . It is also of interest that JunD mRNA is enriched in the ␣CP2-RNPs. Expression of JunD is regulated at the posttranscriptional level (27) by alterations in mRNA stability in response to cellular levels of polyamines. The association of ␣CP2 with JunD mRNA in the present study establishes a testable model in which ␣CP2 may play a role in this process. Thus, both translation and stability controls may be in play via ␣CP2 association with transcription factor mRNAs. VOL. 23, 2003 MICROARRAY IDENTIFICATION OF ␣CP2-ASSOCIATED mRNAS 7065
The presence of four mRNAs encoding interferon-inducible factors in the ␣CP2 RNPs is intriguing, as five different viruses have been reported to utilize ␣CP to regulate viral gene expression (see above). Since interferon is an antiviral agent, it is possible that these viruses have evolved structures that allow them to sequester ␣CP2 from these cellular mRNAs. For example, if ␣CP2 enhances the expression of specific interferoninducible genes, sequestration of ␣CP2 by viral RNAs would inhibit the antiviral response while at the same time possibly enhancing their own expression (3, 4, 11, 12, 33, 51) . The demonstration that expression of RNA decoys can block the functional interaction of ␣CPs with target RNAs in vivo supports several assumptions underlying this model (30) .
A final note concerns ␣CP2 mRNA. The enrichment of ␣CP2 mRNA in ␣CP2-RNP complexes was confirmed by two separate probe sets on the microarray (Table 2 ) and substantiated by directed RT-PCR analysis (Fig. 4B) . This association suggests that ␣CP2 expression may be subject to posttranscriptional autoregulation. A negative autoregulatory loop might mediate tight control over synthesis of the final ␣CP2 product, while a positive loop might amplify the expression of ␣CP2 in certain situations. Further mapping of this interaction and the corresponding mechanistic pathway(s) involved in the proposed autoregulation of ␣CP2 expression are of interest for further study. We thank Gregg Johannes for critical reading of the manuscript and experimental advice.
